Artosi F, Lanna C, Gaeta Shumak R, et al. Tildrakizumab as a Potential Option for Early Psoriatic Arthritis in Patients with Metabolic Comorbidities and Psoriasis: a Case Series. Dermatol Pract Concept. 2025;15(4):5570. doi:10.5826/dpc.1504a5570